The popularity of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has increased in recent years (Rodriguez et al., 2023)
These are authorised health claims under EU Regulation 1924/2006, as listed in Commission Regulation (EU) 432/2012, and they relate specifically to vitamin C as a nutrient
Diabetes 2005, 54:146-151, Bose AK, Mocanu MM, Carr RD, Yellon DM: Glucagon like peptide-1 is protective against myocardial ischemia/ reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model
The scientifically defensible answer is not that BPC-157 raises or lowers blood pressure
Park EY, Shimura N, Konishi T, Sauchi Y, Wada S, Aoi W, et al
Unlike full-length growth hormone, AOD-9604 does not stimulate IGF-1 production or interact with traditional growth hormone receptors, indicating an independent mechanism of action that has been the subject of ongoing investigation